Insiders · BOLD

Nancy Whiting

Director at Boundless Bio, Inc. (BOLD)

Nancy Whiting has filed 10 insider reports with the SEC since August 2021, as director at Boundless Bio, Inc. (BOLD) and director at Caribou Biosciences, Inc. (CRBU). The latest filing, on June 15, 2026, reports grant or award at Boundless Bio, Inc. (BOLD).

Filings
10
Companies
2
Bought on market
None
Sold on market
None

Companies where Nancy Whiting is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Boundless Bio, Inc. logo
BOLD
Boundless Bio, Inc.
Director$2.32Jun 15, 2026
Caribou Biosciences, Inc. logo
CRBU
Caribou Biosciences, Inc.
Directorsince August 2021$0.2843Feb 20, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Nancy Whiting with

Other insiders at the same companies

Questions about Nancy Whiting

What is Nancy Whiting's role at Boundless Bio, Inc.?
Nancy Whiting reports to the SEC as director at Boundless Bio, Inc. (BOLD), according to the latest filing on June 15, 2026. Nancy Whiting has also filed as director at Caribou Biosciences, Inc. (CRBU).
Has Nancy Whiting bought or sold stock recently?
No open-market purchases or sales by Nancy Whiting are on file. The filings report grant or award.
How do I get alerts when Nancy Whiting files?
Follow Nancy Whiting on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Nancy Whiting (SEC CIK 0001880609). Totals count each trade once, skipping amendments whose original is on file, from Aug 31, 2021 on. View on SEC EDGAR · Get this as JSON